Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Prostatic Neoplasms 3Breast Neoplasms 3Neoplasms 2Melanoma 2Breast Neoplasms, Male 2Rectal Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia 1Fallopian Tube Neoplasms 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 59fludarabine phosphate 56Peripheral Blood Stem Cell Transplantation 55Busulfan 42Cyclosporine 39Mycophenolic Acid 35Antilymphocyte Serum 34Filgrastim 32Tacrolimus 31Radiotherapy 31Imatinib Mesylate 28Whole-Body Irradiation 25Methotrexate 24Methylprednisolone 23Cord Blood Stem Cell Transplantation 18sargramostim 16Etoposide 16Dasatinib 16Interferon-alpha 15Cytarabine 15Melphalan 14nilotinib 11Thiotepa 9Therapeutics 9Cyclosporins 9Flow Cytometry 8Psychiatric Rehabilitation 7Polymerase Chain Reaction 6thymoglobulin 5merphos 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Chronic-Phase × saponin QA-21V1 × Clear all
NCT00004052 2013-06-25

Vaccine Therapy in Treating Patients With Chronic Myelogenous Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
24 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡